Weiss Asset Management’s Gracell Biotechnologies Inc. American Depositary Shares GRCL Stock Holding History

Weiss Asset Management’s Portfolio GRCL Stock Details GRCL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-109,400	Closed	-$1.1M	–	522
2023 Q4	$1.1M	Buy	+109,400	New	+$496K	0.05%	151

Weiss Asset Management's GRCL Position: Q1 2024 in Review

Weiss Asset Management sold out of Gracell Biotechnologies Inc. American Depositary Shares (GRCL) in Q1 2024, closing a stake of 109,400 shares — an estimated $1.1M sold.

Weiss Asset Management first reported a position in GRCL in Q4 2023 and held it in 1 quarter. The position peaked at $1.1M in Q4 2023. 0 funds tracked by Wall St. Rank hold GRCL as of Q1 2024.

Weiss Asset Management reported no remaining Gracell Biotechnologies Inc. American Depositary Shares position as of Q1 2024 after selling out during the quarter.
Weiss Asset Management sold 109,400 Gracell Biotechnologies Inc. American Depositary Shares shares in Q1 2024, an estimated $1.1M.
Weiss Asset Management first reported a position in Gracell Biotechnologies Inc. American Depositary Shares in Q4 2023 and held it in 1 quarter.
Weiss Asset Management's Gracell Biotechnologies Inc. American Depositary Shares position peaked at $1.1M in Q4 2023.
0 funds tracked by Wall St. Rank held Gracell Biotechnologies Inc. American Depositary Shares as of Q1 2024.

Based on Weiss Asset Management's 13F filing for Q1 2024, filed 13 May 2024.